Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan P Dyke

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Cell Reports|July 25, 2019
AGO CLIP Reveals an Activated Network for Acute Regulation of Brain Glutamate Homeostasis in Ischemic StrokeMariko Kobayashi, Corinne Benakis, Corey Anderson, et al.
Menopause (New York, N.Y.)|March 11, 2025
Neurophysiological correlates of subjective cognitive decline in perimenopausal and postmenopausal midlife women at risk for Alzheimer's diseaseLisa Mosconi, Schantel Williams, Caroline Carlton, et al.
Neurobiology of Disease|June 1, 2022
Quantifying cerebrospinal fluid dynamics: A review of human neuroimaging contributions to CSF physiology and neurodegenerative diseaseNeel H Mehta, Richard A Suss, Jonathan P Dyke, et al.
Frontiers in Dementia|May 22, 2024
Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife womenMatilde Nerattini, Federica Rubino, Steven Jett, et al.
Plos One|January 13, 2025
Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer's diseaseMatilde Nerattini, Schantel Williams, Caroline Andy, et al.
Human Gene Therapy|May 14, 2008
Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNAStefan Worgall, Dolan Sondhi, Neil R Hackett, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 11, 2013
Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporterAnat Maoz, Martin J Hicks, Shankar Vallabhjosula, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2025
Quantitative and simplified [18F] fluoroestradiol positron emission tomography (PET) measures of brain estrogen receptor expressionMatilde Nerattini, Valentina Berti, Dawn C Matthews, et al.
The Journal of Clinical Investigation|July 11, 2006
Possible axonal regrowth in late recovery from the minimally conscious stateHenning U Voss, Aziz M Uluğ, Jonathan P Dyke, et al.
Cancer Gene Therapy|December 16, 2014
Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastomaMartin J Hicks, Kosuke Funato, Lan Wang, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Cell Reports|July 25, 2019
AGO CLIP Reveals an Activated Network for Acute Regulation of Brain Glutamate Homeostasis in Ischemic StrokeMariko Kobayashi, Corinne Benakis, Corey Anderson, et al.
Menopause (New York, N.Y.)|March 11, 2025
Neurophysiological correlates of subjective cognitive decline in perimenopausal and postmenopausal midlife women at risk for Alzheimer's diseaseLisa Mosconi, Schantel Williams, Caroline Carlton, et al.
Neurobiology of Disease|June 1, 2022
Quantifying cerebrospinal fluid dynamics: A review of human neuroimaging contributions to CSF physiology and neurodegenerative diseaseNeel H Mehta, Richard A Suss, Jonathan P Dyke, et al.
Frontiers in Dementia|May 22, 2024
Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife womenMatilde Nerattini, Federica Rubino, Steven Jett, et al.
Plos One|January 13, 2025
Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer's diseaseMatilde Nerattini, Schantel Williams, Caroline Andy, et al.
Human Gene Therapy|May 14, 2008
Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNAStefan Worgall, Dolan Sondhi, Neil R Hackett, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 11, 2013
Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporterAnat Maoz, Martin J Hicks, Shankar Vallabhjosula, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2025
Quantitative and simplified [18F] fluoroestradiol positron emission tomography (PET) measures of brain estrogen receptor expressionMatilde Nerattini, Valentina Berti, Dawn C Matthews, et al.
The Journal of Clinical Investigation|July 11, 2006
Possible axonal regrowth in late recovery from the minimally conscious stateHenning U Voss, Aziz M Uluğ, Jonathan P Dyke, et al.
Cancer Gene Therapy|December 16, 2014
Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastomaMartin J Hicks, Kosuke Funato, Lan Wang, et al.
Pageof 11